Serum neurotrophic factor levels in patients with type 2 diabetes mellitus: Relationship to metabolic syndrome components

Clinical Laboratory

Volumn 59, Issue 3-4, 2013, Pages 369-374

  Civelek, Sabiha ^a   Konukoglu, Dildar ^a   Erdenen, Fusun ^b   Uzun, Hafize ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Istanbul Education and Research Hospital   (Turkey)

Author keywords

Brain derived neurotrophic factor; Metabolic syndrome; Nerve growth factor; Neurotrophin 3; Type 2 diabetes mellitus

Indexed keywords

ALBUMIN; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; NEUROTROPIN; TRIACYLGLYCEROL;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CALCULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTHROPOMETRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEUROTROPHIN 3;

EID: 84877099074     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120404     Document Type: Article

References (28)

1. Chao MV, Rajagopal R, Lee FS. Neurotrophin signaling in health and disease. Clin Sci 2006;110:167-73.
2. Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment. Behav Pharmacol 2010;21:427-37.
3. Tsuchida A, Nonomura T, Nakagawa T, et al. Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice. Diabetes Obes Metab 2002;4:262-9.
4. Seidel MF, Herguijuela M, Forkert R, Otten U. Nerve growth factor in rheumatic diseases. Semin Arthritis Rheum 2010;40:109-26.
5. Levesque J, Lamarche B. The metabolic syndrome: definitions, prevalence and management. J Nutrigenet Nutrigenomics 2008;1:100-8.
6. Barth RJ. Insulin resistance, obesity and the metabolic syndrome. S D Med 2011;Spec No 22-7.
7. Report of a WHO Consultation, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 Diagnosis and classification of diabetes mellitus. World Health Organization, Department of Noncommunicable Disease Surveillance, Geneva, 1999.
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
9. D'Adamo E, Caprio S. Type 2 diabetes in youth: epidemiology and pathophysiology. Diabetes Care 2011;34 Suppl 2:S161-5.
10. Gupta S, Gupta BM. Metabolic syndrome: diabetes and cardiovascular disease. Indian Heart J 2006;58:149-52.
11. Chaldakov GN, Fiore M, Stankulov IS, et al. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Prog Brain Res 2004;146:279-89.
12. Chaldakov GN, Fiore M, Tonchev AB, Aloe L. Adipopharmacology, a novel drug discovery approach: a metabotrophic perspective. Lett Drug Des Discov 2006;3:503-5.
13. Cai D, Holm JM, Duignan IJ, et al. BDNF-mediated enhancement of inflammation and injury in the aging heart. Physiol Genomics 2006;24:191-7.
14. Ejiri J, Inoue N, Kobayashi S, et al. Possible role of brain derived neurotrophic factor in the pathogenesis of coronary artery disease. Circulation 2005;112:2114-20.
15. Nakahashi T, Fujimura H, Altar CA, et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett 2000;470:113-7.
16. Suwa M, Kishimoto H, Nofuji Y, et al. Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Metabolism 2006;55:852-7.
17. Fujinami A, Ohta K, Obayashi H, et al. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem 2008;41:812-7.
18. Krabbe KS, Nielsen AR, Krogh-Madsen R, et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007;50:431-8.
19. Yamanaka M, Itakura Y, Ono-Kishino M, Tsuchida A, Nakagawa T, Taiji M. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice. J Biosci Bioeng 2008;105:395-402.
20. Rao AA, Sridhar GR, Srinivas B, Das UN. Bioinformatics analysis of functional protein sequences reveals a role for brain-derived neurotrophic factor in obesity and type 2 diabetes mellitus. Medical Hypotheses 2008;70:424-9.
21. Ono M, Ichihara J, Nonomura T, et al. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. Biochem Biophys Res Commun 1997;238:633-7.
22. Konukoglu D, Firtina S, Serin O. The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance. Metabolism 2008;57:110-5.
23. Konukoglu D, Serin O, Turhan MS. Plasma total homocysteine concentrations in obese and non-obese female patients with type 2 diabetes mellitus; its relations with plasma oxidative stress and nitric oxide levels. Clin Hemorheol Microcirc 2005;33:41-6.
24. Hristova M, Aloe L. Metabolic syndrome-neurotrophic hypothesis. Med Hypotheses 2006;66:545-9.
25. Bulló M, Peeraully MR, Trayhurn P, Folch J, Salas-Salvadó J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. Eur J Endocrinol 2007;157:303-10.
26. Ricci A, Bronzetti E, Mannino F, Felici L, Terzano C, Mariotta S. Elevated neurotrophin and neurotrophin receptor expression in spontaneously hypertensive rat lungs. Growth Factors 2004;22:195-205.
27. Clemow DB, Turtle JB. Effects of growth rate and cell density on nerve growth factor secretion in cultures of vascular and bladder smooth muscle cells from hypertensive and hyperactive rats. Cell Tissue Res 1998;294:431-8.
28. Clemow DB, Spitsbergen JM, McCarty R, Steers WD, Turtle JB. Altered NGF regulation may link a genetic predisposition for hypertension with hyperactive voiding. J Urol 1999;161:1372-7.